Abstract:We use the language of multiplier ideals in order to relate the syzygies of an abelian variety in a suitable embedding with the local positivity of the line bundle inducing that embedding. This extends to higher syzygies a result of Hwang and To on projective normality.
“…Our approach builds in part on the method of proof developed in [LPP10]. For the record we state the final result of [LPP10]. Theorem 3.3.1 (Lazarsfeld-Pareschi-Popa).…”
Section: 2mentioning
confidence: 99%
“…Show that L is very ample, but not projectively normal. The essential novelty of our proof is the use of infinitesimal Newton-Okounkov polygons to construct effective Q-divisors whose multiplier ideal coincides with the maximal ideal of the origin; this replaces the straightforward genericity argument of [LPP10].…”
Section: 2mentioning
confidence: 99%
“…From a technical point of view, the essential contribution of the work [LPP10] can be summarized in the following statement. For the sake of clarity we give a quick outline of the argument in [LPP10]; to this end, we quickly recall some terminology. As above, p will denote a natural number, one studies sheaves on the (p + 2)-fold self-product X ×(p+2) .…”
Section: 2mentioning
confidence: 99%
“…To ease the presentation we assume that there exists a Seshadri-exceptional curve F ⊆ X passing through the origin o ∈ X with the property that r def = (L · F) q = mult o (F) 2 and ε def = ε(L; o) = r/q. Our starting point is the method of [LPP10], which builds on the following observation of Green [Gre84] (see also [Ina97]): consider the diagonal ∆ ⊆ X × X with ideal sheaf I ∆ . Projective normality of L is equivalent to the vanishing condition (3.13.6)…”
Section: 2mentioning
confidence: 99%
“…The authors of [LPP10] then go on to show that in order to guarantee the vanishing in (3.13.6), it suffices to verify the existence of an effective Q-divisor…”
“…Our approach builds in part on the method of proof developed in [LPP10]. For the record we state the final result of [LPP10]. Theorem 3.3.1 (Lazarsfeld-Pareschi-Popa).…”
Section: 2mentioning
confidence: 99%
“…Show that L is very ample, but not projectively normal. The essential novelty of our proof is the use of infinitesimal Newton-Okounkov polygons to construct effective Q-divisors whose multiplier ideal coincides with the maximal ideal of the origin; this replaces the straightforward genericity argument of [LPP10].…”
Section: 2mentioning
confidence: 99%
“…From a technical point of view, the essential contribution of the work [LPP10] can be summarized in the following statement. For the sake of clarity we give a quick outline of the argument in [LPP10]; to this end, we quickly recall some terminology. As above, p will denote a natural number, one studies sheaves on the (p + 2)-fold self-product X ×(p+2) .…”
Section: 2mentioning
confidence: 99%
“…To ease the presentation we assume that there exists a Seshadri-exceptional curve F ⊆ X passing through the origin o ∈ X with the property that r def = (L · F) q = mult o (F) 2 and ε def = ε(L; o) = r/q. Our starting point is the method of [LPP10], which builds on the following observation of Green [Gre84] (see also [Ina97]): consider the diagonal ∆ ⊆ X × X with ideal sheaf I ∆ . Projective normality of L is equivalent to the vanishing condition (3.13.6)…”
Section: 2mentioning
confidence: 99%
“…The authors of [LPP10] then go on to show that in order to guarantee the vanishing in (3.13.6), it suffices to verify the existence of an effective Q-divisor…”
In this paper, we show that a general polarized abelian variety of type and dimension g satisfies property if . In particular, the case affirmatively solves a conjecture by Fuentes García on projective normality.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.